science wire

Researchers at Western, London Health Sciences Centre explore how cancer therapy could transform cardiac care George Westerik recently became the first patient at London Health Sciences Centre (LHSC)

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL and Great Ormond Street Hospital (GOSH), has shown promising results in helping children and adults fight a rare and aggressive form of blood cancer.

After scientists at the Comprehensive Cancer Centre of the Medical University of Vienna and the University Hospital Vienna demonstrated the benefits of the 4-valent HPV vaccination in women after sur

The University of Bonn has again succeeded in garnering funding under the GO-Bio initial grant program this year, with as many as six innovative projects attracting 100,000 euros of funding for their conceptual phase.

A young boy born with a devastating, rare genetic condition has been given a new lease of life thanks to a team of UCL scientists who manufactured a pioneering gene therapy for him.

People at high risk of lung cancer will soon be able to receive the first ever experimental vaccine designed to prevent the disease, in a world-first clinical trial led by researchers at UCL and the University of Oxford.

£45m in GSK funding has been allocated to new research programmes combining expertise and using cutting edge AI technology to accelerate AMR research.

A Western-led interdisciplinary research team is using artificial intelligence (AI) to target a potentially harmful enzyme found in the human body that, if left untreated, can cause cancer and infectious disease.

Oxford scientists map the cells that drive Crohn's disease fistulas, paving the way for targeted treatments Scientists at the University of Oxford, have identified how rare populations of abnormal cel

People in their thirties may risk a heart attack or stroke in later life even when they have 'normal' blood pressure, if it's too high or steeply rising, according to a new study led by UCL researchers.

A new treatment for high blood pressure can provide continuous, round-the-clock blood pressure control for people whose condition is hard to treat, according to a global study led by a UCL professor. The treatment, baxdrostat, works by reducing levels of aldosterone, a hormone that can drive high blood pressure in some people.

Posted on: 10 November 2025 A research team from Trinity has unveiled a groundbreaking new approach to vaccination that could redefine how we protect against respiratory infections.

Half of people investigated for suspected angina and given the all-clear may be missing out on the correct diagnosis, according to a new study led by the University of Glasgow. The data was presented at the American Heart Association Scientific Sessions conference in New Orleans, on Monday 10 November 2025, and forms part of a newly published Nature Medicine study, funded by the British Heart Foundation.

Children and young people faced long-lasting and higher risks of rare heart and inflammatory complications after COVID-19 infection, compared to before or without an infection, according to new research. Meanwhile COVID-19 vaccination was only linked to a short-term higher risk of myocarditis and pericarditis.

As new COVID-19 variants continue to appear, many Canadians are wondering whether the updated vaccines still offer strong protection.

Facial tumours in Tasmanian devils are among the few known cases of transmissible cancer. Researchers at the University of Veterinary Medicine, Vienna and the Medical University of Vienna have identified molecular signalling pathways in both variants of this disease that are crucial for the survival and growth of cancer cells.

Reporting side effects makes medicines safer. That is the message of the World Health Organisation (WHO) #MedSafetyWeek, which runs from 3 to 9 November 2025. "Together, we encourage patients, healthcare professionals and health workers to report all suspected side effects - because every report can help protect people," says Health Minister Korinna Schumann, emphasising the benefits of the campaign, which is now in its tenth year.

New eye test based on age-appropriate tasks can lead to earlier detection and treatment of vision problems in children as young as 18 months The development of a new tool for testing the eyesight of children under three could mean more children receive treatment for vision difficulties earlier, leading to positive effects on learning and development.

Results from a study published in The New England Journal of Medicine show that a vaccine can protect people against Salmonella Paratyphi A infection.

UCalgary's Dr. Hossein Piri developing intelligent, personalized alert systems to foster clinician well-being, improve patient care Anyone who has spent more than a few minutes in a hospital has heard the cacophony of persistent alarms.

SUM-101, a new malaria vaccine candidate has shown to be safe and to trigger strong immune responses in adults living in a malaria-endemic region of Tanzania.

A team from the University of Valencia (UV) and the Polytechnic University of Valencia (UPV) has demonstrated the effectiveness of an electrochemical process based on the use of boron-doped diamond to remove pharmaceutical residues from river and lake waters.

A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalised treatment can slow or even halt the progression of the disease.

The 10 organisations in Great Britain that carry out the highest number of animal procedures - those used in medical, veterinary and scientific research - have released their annual statistics today.

Immune defences are at the heart of our ability to respond to disease, but how does the system that protects us every day actually function?

Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much weight people lose while taking the drug, according to a new study led by a UCL researcher.

After being treated with an electronic eye implant paired with augmented-reality glasses, people with sight loss have recovered reading vision, reports a trial involving a UCL and Moorfields clinical researcher.

V2osk  on  Unsplash Age-related macular degeneration (AMD) causes progressive vision loss in many elderly people, and no treatment is available for the so-called atrophic form of the disease.

Writing in The Conversation, Dr Alwyn Dart (UCL Cancer Institute), argues why he believes better prostate cancer tests are required prior to a targeted prostate cancer screening programme being implemented.

A glass plate, a delicate tube and an oil bath are all that is required: thanks to a new method, researchers at ETH Zurich can produce tens of thousands of tiny droplets within minutes.